Can a chemo drug keep sarcoma at bay? new trial aims to find out
NCT ID NCT06981637
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This Phase 2 trial tests whether a chemotherapy drug called pegylated liposomal doxorubicin (PLD) can help people with advanced soft tissue sarcoma live longer without their cancer growing. Participants who have already responded to standard chemotherapy will either receive PLD every 4 weeks for up to 12 cycles or be closely monitored without treatment. The study aims to see if maintenance therapy delays cancer progression compared to active surveillance.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Pegylated liposomal doxorubicin (a chemotherapy drug)
What this could lead to
If successful, this could provide a new maintenance option to delay cancer progression in advanced soft tissue sarcoma patients who have already responded to initial chemotherapy.
What could go wrong
This is a small Phase 2 trial with only 81 participants, so results may not be conclusive. The drug can cause side effects like heart damage or low blood counts, and it may not improve survival.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOFT TISSUE SARCOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Chang Gung Memorial Hospital
NOT_YET_RECRUITINGKaohsiung City, Taiwan
Contact
-
China Medical University Hospital
RECRUITINGTaichung, Taiwan
Contact
-
Kaohsiung Medical University Chung-Ho Memorial Hospital,
RECRUITINGKaohsiung City, Taiwan
Contact
-
National Cheng Kung University Hospital
RECRUITINGTainan, Taiwan
Contact
-
National Taiwan University Hospital
RECRUITINGTaipei, Taiwan
Contact Email: •••••@•••••
-
Taipei Veterans General Hospital
RECRUITINGTaipei, Taiwan
Contact
-
Tri-Service General Hospital
RECRUITINGTaipei, Taiwan
Contact